Matches in Wikidata for { <http://www.wikidata.org/entity/Q63384278> ?p ?o ?g. }
Showing items 1 to 53 of
53
with 100 items per page.
- Q63384278 description "article scientifique publié en 2008" @default.
- Q63384278 description "artículu científicu espublizáu en xunu de 2008" @default.
- Q63384278 description "im Juni 2008 veröffentlichter wissenschaftlicher Artikel" @default.
- Q63384278 description "scientific article published on 20 June 2008" @default.
- Q63384278 description "wetenschappelijk artikel" @default.
- Q63384278 description "наукова стаття, опублікована у квітні 2009" @default.
- Q63384278 name "Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia" @default.
- Q63384278 name "Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia" @default.
- Q63384278 type Item @default.
- Q63384278 label "Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia" @default.
- Q63384278 label "Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia" @default.
- Q63384278 prefLabel "Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia" @default.
- Q63384278 prefLabel "Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia" @default.
- Q63384278 P1433 Q63384278-9958A161-5630-44F5-84F3-9848D29899E6 @default.
- Q63384278 P1476 Q63384278-337C71DB-02D7-4D73-8CF6-8B5656D044AC @default.
- Q63384278 P2093 Q63384278-37533837-EFA4-480C-88E6-802E781F6DF0 @default.
- Q63384278 P2093 Q63384278-5B717FAA-B626-43F8-A323-B09D9E4F5262 @default.
- Q63384278 P2093 Q63384278-97D2BF09-F8C6-421A-B34C-39E58B74A663 @default.
- Q63384278 P2093 Q63384278-AA01BE65-95D5-4174-A0C4-30162E4E28DC @default.
- Q63384278 P2093 Q63384278-E67AFF66-4624-4A15-8338-927BC3DE81AA @default.
- Q63384278 P304 Q63384278-349EE6EF-C91D-49E3-97DD-90EE326AC80E @default.
- Q63384278 P31 Q63384278-72174E8E-3731-4018-B3CA-1A60F0C3E3FE @default.
- Q63384278 P356 Q63384278-063F0EB5-9D09-4272-B3D5-11DE3CAA4EAA @default.
- Q63384278 P433 Q63384278-3C11D0D3-6F53-405A-8A60-26D5D9672263 @default.
- Q63384278 P478 Q63384278-B7EC2F47-0A45-4C89-9784-63BF45365845 @default.
- Q63384278 P50 Q63384278-D4A28EB8-5FD7-4D8D-958A-4EE8C8B61182 @default.
- Q63384278 P50 Q63384278-E0E408F0-3AD5-41F5-97BE-3752814EF785 @default.
- Q63384278 P577 Q63384278-71CDDF5F-21F3-4A9E-B4B0-6AF737442D2D @default.
- Q63384278 P698 Q63384278-8E88E9D1-9712-4E87-8A3F-07AED336A106 @default.
- Q63384278 P921 Q63384278-24B3A680-5EE1-4843-9225-FA41068CBC2E @default.
- Q63384278 P921 Q63384278-6CCFB49E-703C-4F66-8CC8-8BDE33504D46 @default.
- Q63384278 P921 Q63384278-F9F265E2-AEA0-46CE-A8F0-1FB55925F082 @default.
- Q63384278 P356 J.LEUKRES.2008.05.006 @default.
- Q63384278 P698 18571231 @default.
- Q63384278 P1433 Q15716445 @default.
- Q63384278 P1476 "Gemtuzumab Ozogamicin is a promising post-remission therapy for acute myeloid leukemia" @default.
- Q63384278 P2093 "Elias Jabbour" @default.
- Q63384278 P2093 "Hagop Kantarjian" @default.
- Q63384278 P2093 "Hassan A Hatoum" @default.
- Q63384278 P2093 "Rami A Mahfouz" @default.
- Q63384278 P2093 "Zaher K Otrock" @default.
- Q63384278 P304 "565-566" @default.
- Q63384278 P31 Q13442814 @default.
- Q63384278 P356 "10.1016/J.LEUKRES.2008.05.006" @default.
- Q63384278 P433 "4" @default.
- Q63384278 P478 "33" @default.
- Q63384278 P50 Q57964105 @default.
- Q63384278 P50 Q80692775 @default.
- Q63384278 P577 "2008-06-20T00:00:00Z" @default.
- Q63384278 P698 "18571231" @default.
- Q63384278 P921 Q103824 @default.
- Q63384278 P921 Q264118 @default.
- Q63384278 P921 Q29496 @default.